BML Investment Partners, L.P. 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 08:56 am Unchanged | 2025-04-24 | 13D | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,221,546 9.500% | 0 (Unchanged) | Filing |
| 2025-02-14 10:26 am Purchase | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,221,546 9.500% | 38,323 (+0.92%) | Filing |
| 2025-02-14 09:49 am Unchanged | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 0 (Unchanged) | Filing |
| 2024-11-07 12:50 pm Purchase | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 4,183,223 (New Position) | Filing |